Response to Markota et al. “Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia” SCHRES-D-24-00481
Schizophrenia Research · 2024
DOI: 10.1016/j.schres.2024.08.003 ↗Kurz gefasst
Leserbrief in der Zeitschrift Schizophrenia Research, 2024. Verfasst von Helio Elkis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department and Institute of Psychiatry, University of Sao Paulo Medical School (FMUSP), Brazil. Electronic address: helkis@usp.br. Hauptthemen laut MEDLINE: Clozapine, Electroconvulsive Therapy, Antipsychotic Agents. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department and Institute of Psychiatry, University of Sao Paulo Medical School (FMUSP), Brazil. Electronic address: helkis@usp.br.
- Department and Institute of Psychiatry, University of Sao Paulo Medical School (FMUSP), Brazil.
Zitieren
APA
Elkis, H., Melzer-Ribeiro, D. L., & Napolitano, I. C. (2024). Response to Markota et al. “Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia” SCHRES-D-24-00481. Schizophrenia Research. https://doi.org/10.1016/j.schres.2024.08.003
Vancouver
Elkis H, Melzer-Ribeiro DL, Napolitano IC. Response to Markota et al. “Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia” SCHRES-D-24-00481. Schizophrenia Research. 2024. doi:10.1016/j.schres.2024.08.003
BibTeX
@article{Elkis2024,
author = {Elkis, Helio and Melzer-Ribeiro, Debora Luciana and Napolitano, Isabel Cristina},
title = {Response to Markota et al. “Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia” SCHRES-D-24-00481},
journal = {Schizophrenia Research},
year = {2024},
doi = {10.1016/j.schres.2024.08.003}
}
EUVIMED